These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18383807)

  • 41. Seroprevalence of fascioliasis in the eastern region of Turkey: an eight-year investigation.
    Beyhan YE; Yılmaz H
    Turk J Gastroenterol; 2020 Nov; 31(11):746-751. PubMed ID: 33361036
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of nitazoxanide treatment following triclabendazole failure in an outbreak of human fascioliasis in Upper Egypt.
    Ramadan HK; Hassan WA; Elossily NA; Ahmad AA; Mohamed AA; Abd-Elkader AS; Abdelsalam EMN; Khojah HMJ
    PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007779. PubMed ID: 31553716
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fasciola hepatica infection in water buffalo Bubalus bubalis in three provinces of the Nile Delta, Egypt: a cross-sectional study.
    El-Tahawy AS; Kwan N; Sugiura K
    J Vet Med Sci; 2018 Jan; 80(1):28-35. PubMed ID: 29151443
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development and application of a fecal antigen diagnostic sandwich ELISA for estimating prevalence of Fasciola gigantica in cattle in central Java, Indonesia.
    Estuningsih E; Spithill T; Raadsma H; Law R; Adiwinata G; Meeusen E; Piedrafita D
    J Parasitol; 2009 Apr; 95(2):450-5. PubMed ID: 18763850
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Specific IgG avidity in acute and chronic human fascioliasis.
    Abou-Basha LM; Shehab AY; Osman MM; Farag HF
    East Mediterr Health J; 2000; 6(5-6):919-25. PubMed ID: 12197349
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Fasciola hepatica seroprevalence in the Elaziğ region].
    Kaplan M; Kuk S; Kalkan A; Demirdağ K; Ozdarendeli A
    Mikrobiyol Bul; 2002; 36(3-4):337-42. PubMed ID: 12838669
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of IHA test for fascioliasis in cases of hepatitis C virus infection.
    el Abdel Aaty H; Hashim AE
    J Egypt Soc Parasitol; 1996 Aug; 26(2):475-80. PubMed ID: 8754655
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of antibodies against Fasciola hepatica in cirrhotic patients from Peru.
    Marcos LA; Bussalleu A; Terashima A; Espinoza JR
    J Helminthol; 2009 Mar; 83(1):23-6. PubMed ID: 18817587
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fascioliasis an increasing zoonotic disease in Egypt.
    Haridy FM; Ibrahim BB; Morsy TA; El-Sharkawy IM
    J Egypt Soc Parasitol; 1999; 29(1):35-48. PubMed ID: 12561881
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunodiagnosis of human fascioliasis using an antigen of Fasciola gigantica adult worm with the molecular mass of 27 kDa by a dot-ELISA.
    Intapan PM; Maleewong W; Nateeworanart S; Wongkham C; Pipitgool V; Sukolapong V; Sangmaneedet S
    Southeast Asian J Trop Med Public Health; 2003 Dec; 34(4):713-7. PubMed ID: 15115076
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical, laboratory and ultrasonography features of proven human fascioliasis.
    Haseeb AN; El-Shazly AM; Arafa MA; Morsy AT
    J Egypt Soc Parasitol; 2003 Aug; 33(2):397-412. PubMed ID: 14964655
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of immunoglobulin G4 subclass antibody in a peptide-based enzyme-linked immunosorbent assay for the serodiagnosis of human fascioliasis.
    Tantrawatpan C; Maleewong W; Wongkham C; Wongkham S; Intapan PM; Nakashima K
    Parasitology; 2007 Dec; 134(Pt.14):2021-6. PubMed ID: 17714604
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Does human distomiasis due to Fasiola gigantica exist in the delta of the Niger river in Mali? (apropos of a serological survey)].
    Maiga YI; Maiga-Maiga Z; Tembely S; Rhaly AA; Marjolet M; Lepinay-Morel D
    Med Trop (Mars); 1991; 51(3):275-81. PubMed ID: 1943637
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical trial of Mirazid in treatment of human fascioliasis, Ezbet El-Bakly (Tamyia Center) Al-Fayoum Governorate.
    Abo-Madyan AA; Morsy TA; Motawea SM; Morsy AT
    J Egypt Soc Parasitol; 2004 Dec; 34(3):807-18. PubMed ID: 15587309
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of purified antigens in haemagglutination test (IHA) for determination of cross reactivities in diagnosis of fascioliasis and schistosomiasis.
    Azab M el-S ; el Zayat EA
    J Egypt Soc Parasitol; 1996 Dec; 26(3):677-85. PubMed ID: 8918041
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metacercarial precipitin test for diagnosis of human fascioliasis.
    Farag HF; el Sayad MH; Osman MM
    J Trop Med Hyg; 1995 Dec; 98(6):428-30. PubMed ID: 8544226
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human fascioliasis in nomads: A population-based serosurvey in southwest Iran.
    Zoghi S; Emami M; Shahriarirad S; Vahedi R; Cheraghi MR; Zamiri B; Arefkhah N; Ghorbani F; Sarkari B
    Infez Med; 2019 Mar; 27(1):68-72. PubMed ID: 30882381
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Indirect ultra-micro-ELISA for detecting IgG antibodies in patients with fascioliasis].
    Espino AM; Padrón L; Duménigo B; Laferté J
    Rev Cubana Med Trop; 1997; 49(3):167-73. PubMed ID: 9685983
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of the role of some parasitic infections as a cause of acute and chronic hepatic diseases.
    Ghanam ME; Shataat MA; Monib Mel-S; Hassan AA; Younis AI
    J Egypt Soc Parasitol; 2001 Apr; 31(1):37-42. PubMed ID: 12557927
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A monoclonal antibody diagnoses active Fasciola infection in humans.
    Mansour WA; Kaddah MA; Shaker ZA; al Assal FM; Derbala MF
    J Egypt Soc Parasitol; 1998 Dec; 28(3):711-27. PubMed ID: 9914695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.